Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension-Reference-Cited by-同舟云学术

Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension

Published:2015-09-28 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Uschner Frank E.,Ranabhat Ganesh,Choi Steve S.,Granzow Michaela,Klein Sabine,Schierwagen Robert,Raskopf Esther,Gautsch Sebastian,van der Ven Peter F. M.,Fürst Dieter O.,Strassburg Christian P.,Sauerbruch Tilman,Mae Diehl Anna,Trebicka Jonel

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep14573.pdf

Reference47 articles.

1. Friedman, S. L. Mechanisms of Hepatic Fibrogenesis. Gastroenterology 134, 1655–1669 (2008).

2. Sanyal, A. J., Bosch, J., Blei, A. & Arroyo, V. Portal hypertension and its complications. Gastroenterology 134, 1715–1728 (2008).

3. Bosch, J. & García-Pagán, J. C. Complications of cirrhosis. I. Portal hypertension. J. Hepatol. 32, 141–156 (2000).

4. Van de Casteele, M., Sägesser, H., Zimmermann, H. & Reichen, J. Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow. Pharmacol. Ther. 90, 35–43 (2001).

5. Groszmann, R. J. & Abraldes, J. G. Portal hypertension: from bedside to bench. J. Clin. Gastroenterol. 39, S125–130 (2005).

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of liver disease and portal hypertension in cystic fibrosis: a review;Expert Review of Respiratory Medicine;2024-05-03

2. Statins in Chronic Liver Disease: Review of the Literature and Future Role;Seminars in Liver Disease;2024-05

3. Abnormal metabolism in hepatic stellate cells: Pandora's box of MAFLD related hepatocellular carcinoma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

4. Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma;Frontiers in Pharmacology;2024-02-01

5. Dendrobium officinale polysaccharide regulated hepatic stellate cells activation and liver fibrosis by inhibiting the SMO/Gli 1 pathway;Journal of Functional Foods;2024-01